Cargando…

Uncovering the active compounds and effective mechanisms of the dried mature sarcocarp of Cornus officinalis Sieb. Et Zucc. For the treatment of Alzheimer’s disease through a network pharmacology approach

BACKGROUND: Shanzhuyu (the dried mature sarcocarp of Cornus officinalis Sieb. et Zucc., DMSCO) is a Chinese herb that can be used for the treatment of Alzheimer’s disease (AD), but its mechanism remains unknown. The present study aimed to investigate the active ingredients and effective mechanisms o...

Descripción completa

Detalles Bibliográficos
Autores principales: Qu, Yan-Jie, Zhen, Rong-Rong, Zhang, Li-Min, Gu, Chao, Chen, Lei, Peng, Xiao, Hu, Bing, An, Hong-Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249309/
https://www.ncbi.nlm.nih.gov/pubmed/32450873
http://dx.doi.org/10.1186/s12906-020-02951-2
_version_ 1783538564965859328
author Qu, Yan-Jie
Zhen, Rong-Rong
Zhang, Li-Min
Gu, Chao
Chen, Lei
Peng, Xiao
Hu, Bing
An, Hong-Mei
author_facet Qu, Yan-Jie
Zhen, Rong-Rong
Zhang, Li-Min
Gu, Chao
Chen, Lei
Peng, Xiao
Hu, Bing
An, Hong-Mei
author_sort Qu, Yan-Jie
collection PubMed
description BACKGROUND: Shanzhuyu (the dried mature sarcocarp of Cornus officinalis Sieb. et Zucc., DMSCO) is a Chinese herb that can be used for the treatment of Alzheimer’s disease (AD), but its mechanism remains unknown. The present study aimed to investigate the active ingredients and effective mechanisms of DMSCO for the treatment of AD based on a network pharmacology approach. METHODS: The active components of DMSCO were collected from the TCMSP and ETCM databases and the target proteins of these compounds were predicted using TCMSP, SwissTargetPrediction and the STITCH database. The AD-related target proteins were identified from the OMIM, DisGeNet, GEO and GeneCards databases. The network interaction model of the compound-target-disease was established and was used to obtain the key targets of DMSCO on AD through network topology analysis. Subsequently, gene enrichment in Gene Ontology (GO) and KEGG pathways were conducted using the David 6.8 online tool. RESULTS: A total of 30 DMSCO effective compounds and 209 effective drug targets were obtained. A total of 172 AD-related genes and 37 shared targets of DMSCO and AD were identified. A total of 43 key targets for the treatment of AD were obtained from the topological analysis of the DMSCO-AD target network. These key targets were involved in a variety of biological processes, including amyloid deposition, apoptosis, autophagy, inflammatory response and oxidative stress and pathways, such as the PI3K-AKT, MAPK and TNF pathways. Three key compounds, namely ursolic acid, anethole and β-sitosterol were obtained from the analysis of the key targets. CONCLUSIONS: Ursolic acid, anethole and β-sitosterol may be the main active components of DMSCO in the treatment of AD. DMSCO can treat AD by regulating amyloid deposition, apoptosis, autophagy, inflammatory response and oxidative stress via the PI3K-AKT, MAPK and other signaling pathways.
format Online
Article
Text
id pubmed-7249309
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-72493092020-06-04 Uncovering the active compounds and effective mechanisms of the dried mature sarcocarp of Cornus officinalis Sieb. Et Zucc. For the treatment of Alzheimer’s disease through a network pharmacology approach Qu, Yan-Jie Zhen, Rong-Rong Zhang, Li-Min Gu, Chao Chen, Lei Peng, Xiao Hu, Bing An, Hong-Mei BMC Complement Med Ther Research Article BACKGROUND: Shanzhuyu (the dried mature sarcocarp of Cornus officinalis Sieb. et Zucc., DMSCO) is a Chinese herb that can be used for the treatment of Alzheimer’s disease (AD), but its mechanism remains unknown. The present study aimed to investigate the active ingredients and effective mechanisms of DMSCO for the treatment of AD based on a network pharmacology approach. METHODS: The active components of DMSCO were collected from the TCMSP and ETCM databases and the target proteins of these compounds were predicted using TCMSP, SwissTargetPrediction and the STITCH database. The AD-related target proteins were identified from the OMIM, DisGeNet, GEO and GeneCards databases. The network interaction model of the compound-target-disease was established and was used to obtain the key targets of DMSCO on AD through network topology analysis. Subsequently, gene enrichment in Gene Ontology (GO) and KEGG pathways were conducted using the David 6.8 online tool. RESULTS: A total of 30 DMSCO effective compounds and 209 effective drug targets were obtained. A total of 172 AD-related genes and 37 shared targets of DMSCO and AD were identified. A total of 43 key targets for the treatment of AD were obtained from the topological analysis of the DMSCO-AD target network. These key targets were involved in a variety of biological processes, including amyloid deposition, apoptosis, autophagy, inflammatory response and oxidative stress and pathways, such as the PI3K-AKT, MAPK and TNF pathways. Three key compounds, namely ursolic acid, anethole and β-sitosterol were obtained from the analysis of the key targets. CONCLUSIONS: Ursolic acid, anethole and β-sitosterol may be the main active components of DMSCO in the treatment of AD. DMSCO can treat AD by regulating amyloid deposition, apoptosis, autophagy, inflammatory response and oxidative stress via the PI3K-AKT, MAPK and other signaling pathways. BioMed Central 2020-05-25 /pmc/articles/PMC7249309/ /pubmed/32450873 http://dx.doi.org/10.1186/s12906-020-02951-2 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Qu, Yan-Jie
Zhen, Rong-Rong
Zhang, Li-Min
Gu, Chao
Chen, Lei
Peng, Xiao
Hu, Bing
An, Hong-Mei
Uncovering the active compounds and effective mechanisms of the dried mature sarcocarp of Cornus officinalis Sieb. Et Zucc. For the treatment of Alzheimer’s disease through a network pharmacology approach
title Uncovering the active compounds and effective mechanisms of the dried mature sarcocarp of Cornus officinalis Sieb. Et Zucc. For the treatment of Alzheimer’s disease through a network pharmacology approach
title_full Uncovering the active compounds and effective mechanisms of the dried mature sarcocarp of Cornus officinalis Sieb. Et Zucc. For the treatment of Alzheimer’s disease through a network pharmacology approach
title_fullStr Uncovering the active compounds and effective mechanisms of the dried mature sarcocarp of Cornus officinalis Sieb. Et Zucc. For the treatment of Alzheimer’s disease through a network pharmacology approach
title_full_unstemmed Uncovering the active compounds and effective mechanisms of the dried mature sarcocarp of Cornus officinalis Sieb. Et Zucc. For the treatment of Alzheimer’s disease through a network pharmacology approach
title_short Uncovering the active compounds and effective mechanisms of the dried mature sarcocarp of Cornus officinalis Sieb. Et Zucc. For the treatment of Alzheimer’s disease through a network pharmacology approach
title_sort uncovering the active compounds and effective mechanisms of the dried mature sarcocarp of cornus officinalis sieb. et zucc. for the treatment of alzheimer’s disease through a network pharmacology approach
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249309/
https://www.ncbi.nlm.nih.gov/pubmed/32450873
http://dx.doi.org/10.1186/s12906-020-02951-2
work_keys_str_mv AT quyanjie uncoveringtheactivecompoundsandeffectivemechanismsofthedriedmaturesarcocarpofcornusofficinalissiebetzuccforthetreatmentofalzheimersdiseasethroughanetworkpharmacologyapproach
AT zhenrongrong uncoveringtheactivecompoundsandeffectivemechanismsofthedriedmaturesarcocarpofcornusofficinalissiebetzuccforthetreatmentofalzheimersdiseasethroughanetworkpharmacologyapproach
AT zhanglimin uncoveringtheactivecompoundsandeffectivemechanismsofthedriedmaturesarcocarpofcornusofficinalissiebetzuccforthetreatmentofalzheimersdiseasethroughanetworkpharmacologyapproach
AT guchao uncoveringtheactivecompoundsandeffectivemechanismsofthedriedmaturesarcocarpofcornusofficinalissiebetzuccforthetreatmentofalzheimersdiseasethroughanetworkpharmacologyapproach
AT chenlei uncoveringtheactivecompoundsandeffectivemechanismsofthedriedmaturesarcocarpofcornusofficinalissiebetzuccforthetreatmentofalzheimersdiseasethroughanetworkpharmacologyapproach
AT pengxiao uncoveringtheactivecompoundsandeffectivemechanismsofthedriedmaturesarcocarpofcornusofficinalissiebetzuccforthetreatmentofalzheimersdiseasethroughanetworkpharmacologyapproach
AT hubing uncoveringtheactivecompoundsandeffectivemechanismsofthedriedmaturesarcocarpofcornusofficinalissiebetzuccforthetreatmentofalzheimersdiseasethroughanetworkpharmacologyapproach
AT anhongmei uncoveringtheactivecompoundsandeffectivemechanismsofthedriedmaturesarcocarpofcornusofficinalissiebetzuccforthetreatmentofalzheimersdiseasethroughanetworkpharmacologyapproach